Avacopan was safe and effective among patients with respiratory tract manifestations of antineutrophil cytoplasmic antibody-associated vasculitis. Avacopan shows promising efficacy and safety among ...

Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) comes with a heavy quality-of-life burden that doesn't disappear after the early disease phase. This rare but heterogeneous ...

Objective The aim of this study was to investigate the relationship between antineutrophil cytoplasmic antibodies (ANCA) ...

Prophylactic treatment with trimethoprim-sulfamethoxazole (TMP-SMX) significantly reduced the risk for serious infections by approximately 50% in patients with antineutrophil cytoplasmic antibody ...

The investigators identified 38 patients with ANCA-associated vasculitis. Of these patients, 23 had disease associated with ANCAs to proteinase-3, and 15 had disease associated with myeloperoxidase.

Please provide your email address to receive an email when new articles are posted on . SCOTTSDALE, Ariz. — Recent efforts in vasculitis research have seen both “exciting” and “frustrating” results, ...

Myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA)-associated vasculitis is a systemic condition affecting the small vessels with production of MPO-ANCA in serum. It has been suggested ...

Amgen Inc ((AMGN)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Alaska Native and American Indian populations demonstrate notably higher prevalences of ...

Antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis is a severe condition encompassing two major syndromes: granulomatosis with polyangiitis (formerly known as Wegener's granulomatosis) ...